Neurovascular sequestration in paediatric P.falciparum malaria is visible clinically in the retina

  1. Valentina Barrera  Is a corresponding author
  2. Ian JC MacCormick
  3. Gabriela Czanner
  4. Paul Stephenson Hiscott
  5. Valerie Ann White
  6. Alister G Craig
  7. Nicholas Alexander Venton Beare
  8. Lucy Hazel Culshaw
  9. Yalin Zheng
  10. Simon Charles Biddolph
  11. Danny A Milner
  12. Steve Kamiza
  13. Malcolm E Molyneux
  14. Terrie E Taylor
  15. Simon Peter Harding
  1. University of Liverpool, United Kingdom
  2. University of British Columbia, Canada
  3. Liverpool School of Tropical Medicine, United Kingdom
  4. Royal Liverpool University Hospital, United Kingdom
  5. American Society for Clinical Pathology, United States
  6. University of Malawi College of Medicine, Malawi
  7. Malawi-Liverpool-Wellcome Trust Research Programme, Malawi

Abstract

Retinal vessel changes and retinal whitening, distinctive features of malarial retinopathy, can be directly observed during routine eye examination in children with P.falciparum cerebral malaria. We investigated their clinical significance and underlying mechanisms through linked clinical, clinicopathological and image analysis studies. Orange vessels and severe foveal whitening (clinical examination, n=817, OR, 95% CI: 2.90, 1.96-4.30; 3.4, 1.8-6.3, both p<0.001), and arteriolar involvement by intravascular filling defects (angiographic image analysis, n=260, 2.81, 1.17-6.72, p<0.02) were strongly associated with death. Orange vessels had dense sequestration of late stage parasitised red cells (histopathology, n=29; sensitivity 0.97, specificity 0.89) involving 360° of the lumen circumference, with altered protein expression in blood-retinal barrier cells and marked loss/disruption of pericytes. Retinal whitening was topographically associated with tissue response to hypoxia. Severe neurovascular sequestration is visible at the bedside and is a marker of severe disease useful for diagnosis and management.

Article and author information

Author details

  1. Valentina Barrera

    Department of Eye and Vision Science, University of Liverpool, Liverpool, United Kingdom
    For correspondence
    v.barrera@liverpool.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0515-5901
  2. Ian JC MacCormick

    Department of Eye and Vision Science, University of Liverpool, Liverpool, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Gabriela Czanner

    Department of Eye and Vision Science, University of Liverpool, Liverpool, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Paul Stephenson Hiscott

    Department of Eye and Vision Science, University of Liverpool, Liverpool, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Valerie Ann White

    Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada
    Competing interests
    The authors declare that no competing interests exist.
  6. Alister G Craig

    Liverpool School of Tropical Medicine, Liverpool, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Nicholas Alexander Venton Beare

    Department of Eye and Vision Science, University of Liverpool, Liverpool, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Lucy Hazel Culshaw

    Department of Eye and Vision Science, University of Liverpool, Liverpool, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Yalin Zheng

    Department of Eye and Vision Science, University of Liverpool, Liverpool, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Simon Charles Biddolph

    National Specialist Ophthalmic Pathology Service, Royal Liverpool University Hospital, Liverpool, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Danny A Milner

    Center for Global Health, American Society for Clinical Pathology, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Steve Kamiza

    Department of Histopathology, University of Malawi College of Medicine, Blantyre, Malawi
    Competing interests
    The authors declare that no competing interests exist.
  13. Malcolm E Molyneux

    Malawi-Liverpool-Wellcome Trust Research Programme, Blantyre, Malawi
    Competing interests
    The authors declare that no competing interests exist.
  14. Terrie E Taylor

    Blantyre Malaria Project, University of Malawi College of Medicine, Blantyre, Malawi
    Competing interests
    The authors declare that no competing interests exist.
  15. Simon Peter Harding

    Department of Eye and Vision Science, University of Liverpool, Liverpool, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.

Funding

Wellcome (#092668/Z/10/Z)

  • Simon Peter Harding

NIH Clinical Center (#5R01AI034969-11)

  • Terrie E Taylor

Wellcome (#074125)

  • Malcolm E Molyneux

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The core and specific studies all received approval from the Research Ethics Committee at the University of Malawi College of Medicine P. 11/07/593, Michigan State University and the Royal Liverpool and Broadgreen University Hospital Trust n. 3690; research was performed in accordance with the Declaration of Helsinki. Written consent for the clinical eye examination was sought in English or in the language of the parent/guardian who gave permission on the patient's behalf. If a patient died, additional informed written consent for autopsy was sought from the parent/guardian.

Copyright

© 2018, Barrera et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,781
    views
  • 197
    downloads
  • 34
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Valentina Barrera
  2. Ian JC MacCormick
  3. Gabriela Czanner
  4. Paul Stephenson Hiscott
  5. Valerie Ann White
  6. Alister G Craig
  7. Nicholas Alexander Venton Beare
  8. Lucy Hazel Culshaw
  9. Yalin Zheng
  10. Simon Charles Biddolph
  11. Danny A Milner
  12. Steve Kamiza
  13. Malcolm E Molyneux
  14. Terrie E Taylor
  15. Simon Peter Harding
(2018)
Neurovascular sequestration in paediatric P.falciparum malaria is visible clinically in the retina
eLife 7:e32208.
https://doi.org/10.7554/eLife.32208

Share this article

https://doi.org/10.7554/eLife.32208

Further reading

    1. Immunology and Inflammation
    2. Medicine
    Ole Bæk, Tik Muk ... Duc Ninh Nguyen
    Research Article

    Preterm infants are susceptible to neonatal sepsis, a syndrome of pro-inflammatory activity, organ damage, and altered metabolism following infection. Given the unique metabolic challenges and poor glucose regulatory capacity of preterm infants, their glucose intake during infection may have a high impact on the degree of metabolism dysregulation and organ damage. Using a preterm pig model of neonatal sepsis, we previously showed that a drastic restriction in glucose supply during infection protects against sepsis via suppression of glycolysis-induced inflammation, but results in severe hypoglycemia. Now we explored clinically relevant options for reducing glucose intake to decrease sepsis risk, without causing hypoglycemia and further explore the involvement of the liver in these protective effects. We found that a reduced glucose regime during infection increased survival via reduced pro-inflammatory response, while maintaining normoglycemia. Mechanistically, this intervention enhanced hepatic oxidative phosphorylation and possibly gluconeogenesis, and dampened both circulating and hepatic inflammation. However, switching from a high to a reduced glucose supply after the debut of clinical symptoms did not prevent sepsis, suggesting metabolic conditions at the start of infection are key in driving the outcome. Finally, an early therapy with purified human inter-alpha inhibitor protein, a liver-derived anti-inflammatory protein, partially reversed the effects of low parenteral glucose provision, likely by inhibiting neutrophil functions that mediate pathogen clearance. Our findings suggest a clinically relevant regime of reduced glucose supply for infected preterm infants could prevent or delay the development of sepsis in vulnerable neonates.

    1. Medicine
    2. Microbiology and Infectious Disease
    Kavidha Reddy, Guinevere Q Lee ... Thumbi Ndung'u
    Research Article

    Persisting HIV reservoir viruses in resting CD4 T cells and other cellular subsets are a barrier to cure efforts. Early antiretroviral therapy (ART) enables post-treatment viral control in some cases, but mechanisms remain unclear. We hypothesised that ART initiated before peak viremia impacts HIV-1 subtype C reservoirs. We studied 35 women at high risk of infection from Durban, South Africa, identified with hyperacute HIV by twice-weekly HIV-RNA testing. Participants included 11 starting ART at a median of 456 (297–1203) days post-onset of viremia (DPOV) and 24 at 1 (1–3) DPOV. Peripheral blood mononuclear cells (PBMCs) were used to measured total HIV-1 DNA by droplet digital PCR (ddPCR) and sequence viral reservoir genomes by full-length proviral sequencing (FLIP-seq). ART during hyperacute infection blunted peak viremia (p<0.0001), but contemporaneous total HIV-1 DNA did not differ (p=0.104). Over 1 year, a decline of total HIV-1 DNA was observed in early treated persons (p=0.0004), but not late treated. Among 697 viral genome sequences, the proviral genetic landscape differed between untreated, late treated, and early treated groups. Intact genomes after 1 year were higher in untreated (31%) versus late treated (14%) and early treated (0%). Treatment in both late and early infection caused more rapid decay of intact (13% and 51% per month) versus defective (2% and 35%) viral genomes. However, intact genomes persisted 1 year post chronic treatment but were undetectable with early ART. Early ART also reduced phylogenetic diversity of intact genomes and limited cytotoxic T lymphocyte immune escape variants in the reservoir. Overall, ART initiated in hyperacute HIV-1 subtype C infection did not impact reservoir seeding but was associated with rapid intact viral genome decay, reduced genetic complexity, and limited immune escape, which may accelerate reservoir clearance in combination with other interventional strategies.